Breaking News
Get 45% Off 0
😎 Watchlist Weekend: Get instant access to see which stocks billionaires are buying
Copy for FREE

MarketBeat.com MarketBeat.com

MarketBeat.com's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by MarketBeat.com, including current material.
Digital Turbine Stock Is A Dual Narrative Winner By Jea Yu  - Feb 09, 2021

Mobile advertising and content technology platform provider Digital Turbine (NASDAQ:APPS) stock has been on an explosive rise propelled by the increase in mobile device usage and economic recovery....

RealNetworks Stock A Legacy Reemergence Play By Jea Yu  - Feb 05, 2021

Legacy media and entertainment platform RealNetworks (NASDAQ:RNWK)) stock has reversed its multi-year downtrend. The year 2021 has seen a resurgence of legacy momentum stocks and former high fliers...

Kforce Stock Is A Workforce Recovery Play By Jea Yu  - Feb 04, 2021

Professional staffing solutions provider Kforce (NASDAQ:KFRC) stock has been trying to break three-year highs on the acceleration of the post-pandemic economic recovery. Shares are tracking the...

Pinterest Will Be Post-Pandemic Winner Too By Nick Vasco  - Feb 03, 2021

Pinterest (NYSE:PINS) is set to report its Q4 earnings tomorrow after the bell. The online product and idea discovery platform has been one of the biggest pandemic winners; shares have roughly...

Lithium Americas Stock Is A Buy By Jea Yu  - Feb 02, 2021

Lithium junior miner, Lithium Americas (NYSE:LAC) stock has surged on the prospects of mining and supplying lithium to the ever hungry electric vehicle (EV) battery segment. The race for EV battery...

3 Silver Stocks To Watch This Month By Sean Sechler  - Feb 02, 2021 1

With volume in the iShares Silver Trust ETF seeing one of its biggest days ever in Monday’s trading session and a recent surge in the price of silver to the highest levels since February 2013,...

AbbVie: A Classic Buy The Dip Candidate By Chris Markoch  - Feb 01, 2021 3

AbbVie (NYSE:ABBV) will report earnings before the market opens on Wednesday, Feb. 3, 2021. The biopharmaceutical giant is expected to post earnings per share and revenue that mark both a sequential...

Continue with Apple
Continue with Google
or
Sign up with Email